Although t(4;11)(q21;q23) leading to a KMT2A–AFF1 fusion is a molecular marker of infant acute lymphoblastic leukemia (ALL), it can occur at any age, and is rarely also found in AML. The gene discussed is KMT2A; the disease is acute myeloid leukemia.